Insight 2811’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Sell
1,082
-14
-1% -$3.26K 0.1% 96
2026
Q2
$260K Buy
1,096
+7
+0.6% +$1.46K 0.1% 88
2026
Q1
$230K Buy
1,089
+29
+3% +$6.24K 0.1% 87
2025
Q4
$218K Buy
+1,060
New +$199K 0.1% 92
2022
Q4
– Sell
-9,854
Closed -$657K – 96
2022
Q3
$657K Buy
9,854
+126
+1% +$7.99K 0.44% 24
2022
Q2
$508K Buy
9,728
+139
+1% +$7.9K 0.33% 36
2022
Q1
$544K Buy
+9,589
New +$514K 0.32% 34

Other funds holding CAH

Insight 2811's CAH Position: Q3 2026 in Review

Insight 2811 reduced its Cardinal Health (CAH) stake by 1.3% in Q3 2026, selling an estimated $3.26K and leaving 1,082 shares worth $241K. The position accounts for 0.1% of the portfolio, ranked #96.

Insight 2811 first reported a position in CAH in Q1 2022 and has held it in 7 quarters since. The position peaked at $657K in Q3 2022. 1,295 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Insight 2811 held 1,082 shares of Cardinal Health worth $241K as of Q3 2026.
  • Insight 2811 sold 14 Cardinal Health shares in Q3 2026, an estimated $3.26K.
  • Cardinal Health made up 0.1% of Insight 2811's portfolio in Q3 2026, its #96 holding.
  • Insight 2811 first reported a position in Cardinal Health in Q1 2022 and has held it in 7 quarters since.
  • Insight 2811's Cardinal Health position peaked at $657K in Q3 2022.
  • 1,295 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Insight 2811's 13F filing for Q3 2026, filed 6 Nov 2026.